These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 6728249)

  • 1. [Value of the study of occult fecal blood with Hemoccult II in 211 symptomatic patients controlled by total colonoscopy].
    Morini S; Manurita L; Stroppa I; Bassi O
    Minerva Med; 1984 Apr; 75(17):963-6. PubMed ID: 6728249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of the Hemoccult II slide test in detecting colonic neoplasms.
    Poleski MH; Gordon PH
    Can J Surg; 1986 Mar; 29(2):99-101. PubMed ID: 3955472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult faecal blood loss determined by a 51Cr method and chemical tests in patients referred for colonoscopy.
    Dybdahl JH; Daae LN; Larsen S; Myren J
    Scand J Gastroenterol; 1984 Mar; 19(2):245-54. PubMed ID: 6609422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of fecal occult-blood tests for colorectal-cancer screening.
    Allison JE; Tekawa IS; Ransom LJ; Adrain AL
    N Engl J Med; 1996 Jan; 334(3):155-9. PubMed ID: 8531970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endoscopic diagnoses in patients with positive Hemoccult-test: critical consideration and negative Hemoccult-test (author's transl)].
    Kruis W; Weinzierl M; Eisenberg J
    Med Klin; 1979 Nov; 74(44):1641-4. PubMed ID: 522810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A controlled study on the significance of occult blood test in the stool (author's transl)].
    Schüler HO; Braungardt H
    MMW Munch Med Wochenschr; 1979 Nov; 121(44):1465-8. PubMed ID: 118339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colocare self-test versus Hemoccult II Sensa for fecal occult blood testing.
    Foliente RL; Wise GR; Collen MJ; Abdulian JD; Chen YK
    Am J Gastroenterol; 1995 Dec; 90(12):2160-3. PubMed ID: 8540507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Randomized population study of screening for intestinal cancer with Hemoccult-II].
    Kronborg O; Fenger C; Olsen J; Jørgensen OD; Søndergaard O
    Ugeskr Laeger; 1997 Aug; 159(33):4977-81. PubMed ID: 9281212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Practical experiences with the stool test for occult blood].
    Gnauck R
    Schweiz Med Wochenschr; 1983 Apr; 113(15):528-34. PubMed ID: 6857203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rectoscopy and Hemoccult II in irritable colon. A prospective study].
    Hovendal CP; Kronborg O; Hem J; Grinsted P; Fenger C
    Ugeskr Laeger; 1990 Sep; 152(38):2732-4. PubMed ID: 2219505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical comparison of hemoFEC with Hemoccult II (author's transl)].
    Gnauck R
    Dtsch Med Wochenschr; 1978 Oct; 103(42):1648-9. PubMed ID: 699787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood.
    Shields HM; Weiner MS; Henry DR; Lloyd JA; Ransil BJ; Lamphier DA; Gallagher DW; Antonioli DA; Rosner BA
    Am J Gastroenterol; 2001 Jan; 96(1):196-203. PubMed ID: 11197252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
    Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC
    Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Haemoscreen in comparison with haemoccult as screening test for colorectal carcinoma (author's transl)].
    Gnauck R; Thomas L
    Dtsch Med Wochenschr; 1980 Nov; 105(47):1643-6. PubMed ID: 7439045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening tests for colon cancer - a new comparison Haemoccult - hemoFEC and review of 9 years clinical experience with Haemoccult (author's transl)].
    Gnauck R
    Z Gastroenterol; 1982 Feb; 20(2):84-92. PubMed ID: 6977955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy.
    Liu HH; Huang TW; Chen HL; Wang TH; Lin JT
    Hepatogastroenterology; 2003; 50(53):1390-2. PubMed ID: 14571744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DNA test as colon cancer screening. Hemoccult and colonoscopy are actually more reliable].
    Freitag MH
    MMW Fortschr Med; 2005 Apr; 147(16):10. PubMed ID: 16392392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.